[
    [
        {
            "time": "2019-07-07",
            "orginal_text": "【山证医药】医药行业周报（20190707）：医保控费形势依然严峻，创新药研发热情高涨",
            "features": {
                "keywords": [
                    "医保控费",
                    "创新药",
                    "研发热情"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "【山证医药】医药行业周报（20190707）：医保控费形势依然严峻，创新药研发热情高涨",
            "scores": {
                "News_content": "【山证医药】医药行业周报（20190707）：医保控费形势依然严峻，创新药研发热情高涨",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "2019-07-01 to 2019-07-05",
            "orginal_text": "医药生物全球视野–西南证券海外医药一周资讯（2019.7.1-2019.7.5）【西南医药朱国广陈铁林团队】",
            "features": {
                "keywords": [
                    "全球视野",
                    "海外医药",
                    "一周资讯"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药生物全球视野–西南证券海外医药一周资讯（2019.7.1-2019.7.5）【西南医药朱国广陈铁林团队】",
            "scores": {
                "News_content": "医药生物全球视野–西南证券海外医药一周资讯（2019.7.1-2019.7.5）【西南医药朱国广陈铁林团队】",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 3,
                "Headline_Structure": 5,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "orginal_text": "医疗保健：北上资金增配医疗器械领域",
            "features": {
                "keywords": [
                    "北上资金",
                    "医疗器械"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗保健",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医疗保健：北上资金增配医疗器械领域",
            "scores": {
                "News_content": "医疗保健：北上资金增配医疗器械领域",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "orginal_text": "复星医药(02196-HK)控股子公司拟购入力思特制药股权",
            "features": {
                "keywords": [
                    "复星医药",
                    "控股子公司",
                    "力思特制药",
                    "股权收购"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "复星医药(02196-HK)控股子公司拟购入力思特制药股权",
            "scores": {
                "News_content": "复星医药(02196-HK)控股子公司拟购入力思特制药股权",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "orginal_text": "复星医药子公司复宏汉霖赴港上市",
            "features": {
                "keywords": [
                    "复星医药",
                    "复宏汉霖",
                    "赴港上市"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "复星医药子公司复宏汉霖赴港上市",
            "scores": {
                "News_content": "复星医药子公司复宏汉霖赴港上市",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]